Skip to content

Relife

Active
Private limited companyfounded 2023active for 3 yearsBorchtstraat 30, 2800 Mechelen, Belgium11 active companies are registered at this addressKBO/BCE: BE 1000.175.809
Summary

The computed 12-month bankruptcy probability of Relife is 4.5% (elevated). The 2024 annual accounts show negative equity (-€953) and a net result of -€1,986. Its solvency ranks better than 5% of 37,596 sector peers (NACE 70, financial year 2024). The company has been active since 2023 and the Belgian Official Gazette contains no insolvency or warning signals.

History

Relife was incorporated on 22 September 2023 as a private limited company.1 The registered office was moved to Mechelen in 2026.2 The company has filed 2 sets of annual accounts, the latest for financial year 2024.3

  1. 1KBO register
  2. 2Belgian Official Gazette, 05-05-2026
  3. 3National Bank, annual accounts 2024

Acts, filings and financial milestones

2026
05-05
Gazette deed Resignations: Valesca Vervoort (director) and SANDRA DE RUYSSCHER (director)
Appointment: Joeri Perneel (director) · Registered-office move · Power of attorney8 facts ▸
  • General meeting, 04-03-2026
  • Director resignation, Valesca Vervoort (director (not named in the articles))
  • Director resignation, SANDRA DE RUYSSCHER (director (not named in the articles))
  • Director appointment, Joeri Perneel (director (not named in the articles))
  • Registered-office move, Borchtstraat 30/ 201, 2800 Mechelen
  • Power of attorney, BV Meesters Accountants
  • Power of attorney (2 times)
  • Declaration, “Bijzondere verklaring in toepassing van de wet betreffende het Centraal register van bestuursverboden van 04-05-2023, bijzondere volmacht” (deed in Dutch)
2025
10-06
NBB filing Annual accounts filed
financial year 2024 · micro format
2024
29-07
NBB filing Annual accounts filed
financial year 2023 · micro format
Gazette deedNBB filing
1 of 2 deeds read
About the unread acts

Of the 2 Belgian Official Gazette deeds we know for this company, 1 has been read. The other one has not been read yet: what they contain is neither established nor disproved here.

Have them read with priority Sign in to place this company at the front of the reading queue.